ABSTRACT
Hepatitis E is a not uncommon cause of viral hepatitis globally but is relatively rare in Australia. Here, we report a case of acute hepatitis E that was acquired in Sydney and was part of a cluster believed to be infected locally. This is to our knowledge the first known outbreak of locally acquired hepatitis E in Australia. We discuss pathogenesis, clinical features and means by which further spread of infection can be limited.
Subject(s)
Cross Infection/prevention & control , Hepatitis E virus/isolation & purification , Hepatitis E/diagnosis , Medical Staff, Hospital , Adult , Australia/epidemiology , Communicable Disease Control , Disease Outbreaks , Hepatitis E/blood , Hepatitis E/epidemiology , Humans , Liver Function Tests/methods , Male , New South Wales/epidemiology , Public HealthABSTRACT
An association between inflammatory bowel disease (IBD) and multiple sclerosis (MS) has been described. The current study was undertaken to explore this association further. Personal records of patients with IBD and MS were reviewed. In addition, a search of medical records at a large tertiary teaching hospital in Sydney was carried out for the years 1996-2006. Four patients (three women and one man) with both ulcerative colitis and MS were identified. MS did not occur in any of our patients with Crohn's disease. The association between ulcerative colitis and MS appears to be real and may help identify common factors involved in the cause of these two diseases. No association was found in this study between MS and Crohn's disease, sparking consideration why such difference should occur. With the increasing use of biological therapies in IBD and their reported propensity to cause demyelination, recognition of an association is all the more important.
Subject(s)
Colitis, Ulcerative/complications , Colitis, Ulcerative/diagnosis , Multiple Sclerosis/complications , Multiple Sclerosis/diagnosis , Adult , Aged , Female , Humans , Male , Retrospective StudiesABSTRACT
Microscopic forms of colitis (collagenous colitis and lymphocytic colitis) are uncommon but important causes of chronic diarrhoea that are often overlooked. The clinical features of these disorders are similar, and they are more common in middle-aged females, although the female predominance is greater in collagenous colitis. Although their cause is unclear, both are associated with a variety of autoimmune diseases. Colonoscopy and barium enema are typically normal, so that the diagnosis depends on the demonstration of characteristic changes on histopathological examination of colorectal biopsies. These should be taken in all patients undergoing colonoscopy for the investigation of chronic diarrhoea. There are no large controlled trials of therapy available. Treatment is empirical, generally using the same agents as for inflammatory bowel -disease. Assessment of therapy is also difficult as spontaneous remissions occur often.
Subject(s)
Biopsy, Needle , Colitis/pathology , Diarrhea/pathology , Adult , Aged , Australia/epidemiology , Chronic Disease , Colitis/drug therapy , Colitis/epidemiology , Collagen/metabolism , Colonoscopy/methods , Diarrhea/drug therapy , Diarrhea/epidemiology , Female , Gastrointestinal Agents/therapeutic use , Humans , Immunohistochemistry , Incidence , Intestinal Mucosa/pathology , Lymphocytosis , Male , Middle Aged , Prognosis , Randomized Controlled Trials as Topic , Risk Assessment , Sensitivity and Specificity , Severity of Illness Index , Steroids/therapeutic use , Treatment OutcomeABSTRACT
Collagenous colitis is a form of microscopic colitis that results in chronic watery diarrhea. The disorder predominantly affects middle-aged women, and its course tends to be benign. It is not thought to be a precursor of overt inflammatory bowel disease; however, apparent progression to ulcerative colitis has been reported on one previous occasion. We describe two further patients with symptoms and histologic features of collagenous colitis who subsequently developed ulcerative colitis. The first patient developed ulcerative colitis 13 months after diagnosis of collagenous colitis, although she gave a 23-year history of profuse watery diarrhea, which had not been adequately investigated. In the second patient, collagenous colitis was diagnosed soon after the onset of watery diarrhea, and 12 months later, progression to ulcerative colitis was documented. Both patients tested positive for perinuclear antineutrophil cytoplasmic antibody after they developed ulcerative colitis; the first patient was initially negative. In conclusion, these two cases, in addition to the one other in the literature, suggest that collagenous colitis and ulcerative colitis may represent extremes in the spectrum of inflammatory bowel disease and that collagenous colitis may evolve to ulcerative colitis. Therefore, progression to ulcerative colitis should be considered in any patient with known collagenous colitis whenever bloody diarrhea occurs, or if red cells, as well as white cells, are noted on stool microscopy.
Subject(s)
Colitis, Ulcerative/physiopathology , Colitis/pathology , Aged , Colitis, Ulcerative/pathology , Collagen , Colonoscopy , Disease Progression , Female , Humans , Middle AgedABSTRACT
The case of a 13-year-old female presenting with a 6 week history of significant vomiting resulting from a gastric duplication is described. At endoscopy, an antral mass which appeared to change in size and site with peristalsis was evident. Although rare, these lesions need to be considered in the differential diagnosis of patients presenting with symptoms suggestive of gastric outlet obstruction. However, in the majority of cases, the diagnosis is rarely made prior to surgery.
Subject(s)
Gastric Outlet Obstruction/etiology , Stomach Diseases/congenital , Stomach/abnormalities , Adolescent , Endoscopy , Female , Humans , Stomach Diseases/diagnosis , Vomiting/etiologyABSTRACT
The cases of two fraternal sisters with symptomatic biliary obstruction due to adenomas of the ampulla of Vater are reported. Both sisters had autosomal dominant adult polycystic kidney disease. There are no previous reports of a familial occurrence of ampullary adenomas in the absence of familial adenomatous polyposis, nor has an association between autosomal dominant polycystic kidney disease and ampullary adenoma been described. The coexistence of both disorders in these sisters raises the possibility of a genetic link between autosomal dominant polycystic kidney disease and ampullary adenoma.
Subject(s)
Adenoma/complications , Ampulla of Vater , Common Bile Duct Neoplasms/complications , Polycystic Kidney Diseases/complications , Adenoma/genetics , Common Bile Duct Neoplasms/genetics , Family Health , Female , Genes, Dominant , Humans , Middle Aged , Polycystic Kidney Diseases/geneticsABSTRACT
BACKGROUND: Upper gastrointestinal (UGI) bleeding is a relatively common and potentially fatal complication of coronary artery bypass graft (CABG) surgery. However, little is known of this problem, including its incidence, predisposing factors and safety of endoscopy in these patients. AIM: To document the incidence, site, predisposing factors and outcome of UGI bleeding following CABG surgery. Also, to assess the safety of UGI endoscopy in these patients. METHOD: Retrospective study of UGI haemorrhage following CABG at one institution between 1976 and 1991. RESULTS: Fifty-five of 10,573 patients (0.5%) suffered a major UGI haemorrhage (as defined by need for transfusion or presence of melaena or haematemesis associated with hypotension). Of 51 patients undergoing endoscopy or laparotomy, 42 (82%) bled from duodenal ulceration. Five patients bled from gastric ulcers and one each from oesophagitis and Mallory Weiss tear. Nine patients underwent endoscopic therapy, which initially arrested haemorrhage in eight patients. However, three patients rebled and required surgery. Eight patients underwent surgery as initial therapy, resulting in an overall surgical rate of 20%. One patient died due to multi system failure following surgery. There were no complications from endoscopy. Patients who bled were more likely to have received inotropic support post-operatively prior to the haemorrhage (p < 0.05) and tended to be older than controls (mean age 65.6 years vs 58.7 years, p < 0.01). Twenty-one of the patients (38%) who bled had a past history of peptic ulceration or dyspepsia compared with 9% of controls (p < 0.001). Seven (12.5%) had previously bled from peptic ulceration. Patients who bled were less likely to have received H2-receptor antagonists in the perioperative period than controls (4% vs 20%, p < 0.05). CONCLUSION: Upper GI haemorrhage following CABG is relatively frequent. It is usually secondary to duodenal ulceration. Endoscopy is a safe procedure in this patient group. Mortality did not differ between index patients who suffered a UGI haemorrhage and controls undergoing CABG who did not bleed.
Subject(s)
Coronary Artery Bypass/adverse effects , Gastrointestinal Hemorrhage/etiology , Aged , Duodenal Ulcer/complications , Female , Humans , Male , Retrospective StudiesABSTRACT
Thirty-one patients were randomized during 39 episodes of bleeding to receive either 1 g of intravenous cefotaxime (19 patients) or no antibiotic (20 patients) immediately before emergency endoscopic sclerotherapy. Blood was obtained for culture before and at 5 minutes, 4 hours, and 24 hours after the procedure. Specimens for culture were taken from the endoscope tip and channel, water bottle, and injection needle after sclerotherapy. When ascites was present (5 patients in the antibiotic group, 7 in the control group), fluid was obtained by paracentesis before endoscopy and at 4 and 24 hours. Bacteremia occurred in 1 of 19 patients in the antibiotic group (5.3%), compared with 6 of 19 in the control group (31.6%; p = .04). The cultured organisms were oral flora and usually also contaminated the endoscope and needle. No bacteria were cultured from ascitic fluid in any patient nor was the ascitic fluid white cell count elevated. Clinical infection attributable to sclerotherapy did not develop in any patient. In conclusion, the frequency of bacteremia after endoscopic sclerotherapy for bleeding esophageal varices can be reduced by prophylactic administration of intravenous cefotaxime. However, this may not be clinically relevant, given the absence of bacterascites and infection in this study. These findings do not support the routine use of antibiotics before sclerotherapy.
Subject(s)
Ascites/etiology , Ascites/prevention & control , Bacteremia/etiology , Bacteremia/prevention & control , Bacterial Infections/etiology , Bacterial Infections/prevention & control , Cefotaxime/administration & dosage , Esophageal and Gastric Varices/therapy , Gastrointestinal Hemorrhage/therapy , Sclerotherapy/adverse effects , Endoscopy, Gastrointestinal , Equipment Contamination , Female , Humans , Injections, Intravenous , Male , Middle AgedABSTRACT
Considerable variability has been reported in the frequency and specificity of anti-neutrophil cytoplasmic antibody with a perinuclear staining pattern (pANCA) in patients with chronic liver disease, especially in primary sclerosing cholangitis (PSC), and in inflammatory bowel disease. This study examines the presence of pANCA in patients with these disorders, in particular those with PSC complicated by other biliary disease, and also patients who had undergone orthotopic liver transplantation. An indirect immunofluorescent technique was used to measure pANCA with serum diluted 1:20. Ten of 39 (26%) patients with PSC had detectable pANCA, as did two of nine (22%) with autoimmune chronic active hepatitis (AICAH) but none of the 51 patients with other forms of chronic liver disease. The presence of pANCA was significantly more frequent in patients who had PSC with biliary tract complications, in particular calculi (seven of 16 with vs three of 23 without; P = 0.03). Eight of the 12 pANCA-positive patients with PSC or AICAH had undergone hepatic transplantation. This was more likely than in patients with PSC or AICAH who were pANCA negative (10 of 36; P = 0.02). To date, pANCA has been detected after transplantation in four patients with PSC and one with AICAH. In patients with PSC or AICAH, pANCA should be sought as a marker of prognosis.
Subject(s)
Autoantibodies/analysis , Cholangitis, Sclerosing/immunology , Adult , Aged , Antibodies, Antineutrophil Cytoplasmic , Biliary Tract Diseases/complications , Biomarkers , Cholangitis, Sclerosing/complications , Colitis, Ulcerative/complications , Colitis, Ulcerative/immunology , Crohn Disease/complications , Female , Humans , Liver Transplantation , Male , Middle Aged , Postoperative PeriodSubject(s)
Bile Duct Diseases/diagnosis , Blood Coagulation Tests , Liver Diseases/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prospective Studies , Reproducibility of Results , Time FactorsABSTRACT
The clinical features of 61 patients with sclerosing cholangitis were reviewed. This group included 23 patients with biliary tract calculi, commonly considered as excluding the diagnosis of primary sclerosing cholangitis. The aim of this study was to compare these 23 patients (group A) with 38 patients with sclerosing cholangitis free of calculi (group B). Both groups had the following features in common: (i) age at presentation, (ii) incidence of inflammatory bowel disease, (iii) extent of radiological disease, (iv) prevalence of HLA-B8 and DR3 haplotype, (v) incidence of cholangiocarcinoma, and (vi) progression to hepatic transplantation (mean follow up 49.9 months). All patients in group A were symptomatic at diagnosis compared with 23 of the 38 patients (61%) in group B. Recurrent ascending cholangitis occurred in 12 patients in group A (52%) and two patients (5%) in group B. The similarity between the two groups was maintained when the nine patients in group A who developed calculi after sclerosing cholangitis was diagnosed were excluded. It is concluded that choledocholithiasis is part of the spectrum of primary sclerosing cholangitis and that it is not necessary to invoke choledocholithiasis as the initial lesion of the bile ducts in such patients.
Subject(s)
Cholangitis, Sclerosing/complications , Cholelithiasis/complications , Adolescent , Adult , Aged , Cholangiopancreatography, Endoscopic Retrograde , Cholangitis, Sclerosing/diagnostic imaging , Cholelithiasis/diagnostic imaging , Colitis, Ulcerative/diagnostic imaging , Female , Humans , Male , Middle AgedABSTRACT
The use of antibiotics in patients with cystic fibrosis is widespread, and fecal carriage of Clostridium difficile occurs in up to 50% of these patients; however, antibiotic-associated colitis appears to be a rare occurrence. The reasons why this is so remain unknown. A case of antibiotic-associated colitis occurring in a patient with cystic fibrosis is described. Possible mechanisms for the rarity of antibiotic-associated colitis are reviewed and implications for prompt diagnosis and therapy are discussed.
Subject(s)
Cystic Fibrosis/complications , Enterocolitis, Pseudomembranous/complications , Adult , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Clostridioides difficile/isolation & purification , Cystic Fibrosis/microbiology , Enterocolitis, Pseudomembranous/chemically induced , Humans , Male , Pseudomonas Infections/complications , Pseudomonas Infections/drug therapyABSTRACT
Inflammatory pseudotumors of the liver are rare lesions that are becoming increasingly recognized, possibly because of frequent use of abdominal computed tomography (CT) and ultrasonography. Most previously reported cases have been treated by hepatic resection. For this reason, we describe a patient with obstructive jaundice secondary to an inflammatory hepatic pseudotumor in the porta hepatis. Bilateral internal biliary stents were inserted, and the patient remains well 5 years later. The clinicopathologic features of inflammatory pseudotumors of the liver are described, as are the implications of accurate diagnosis. There have been no previous reports of biliary stenting in management of inflammatory hepatic pseudotumors.
Subject(s)
Cholestasis/etiology , Cholestasis/therapy , Fibroma/complications , Liver Neoplasms/complications , Stents , Adult , Diagnostic Errors , Fibroma/diagnosis , Follow-Up Studies , Humans , Lymphoma, Non-Hodgkin/diagnosis , MaleABSTRACT
The case is presented of a 19 year-old male who was diagnosed as suffering from Goodpasture's syndrome, treated with reducing doses of prednisone and chlorambucil for 12 months and who developed Hodgkin's disease 16 years later. Various postulates to explain the occurrence of Hodgkin's disease in this patient are proposed, and the possible association between Goodpasture's syndrome and Hodgkin's disease is discussed with reference to iatrogenic, genetic, environmental and immunological factors.